Clinical Trials Directory

Trials / Completed

CompletedNCT02332603

Effect of Methylprednisolone on Glucose Homeostasis in Patients Undergoing Total Hip- and Knee-arthroplasty

Effect of Preoperative Intravenous High Dose Methylprednisolone on Glucose Homeostasis in Patients Scheduled for Total Hip- and Knee-arthroplasty

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
55 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the pathophysiological effects of a single dose of Methylprednisolone administered prior to total hip- and knee-arthroplasty surgery. The investigators examine the effect on blood glucose homeostasis. Half of participants will receive intravenous Solu-Medrol 125 mg, while the other half will receive placebo. The investigators hypothesize that the glucose homeostasis remains equally stable in the group receiving Methylprednisolone as in the group receiving placebo.

Detailed description

The anti-inflammatory effects of glucocorticoids are well known. The beneficial effects on postoperative pain, postoperative nausea and vomiting are well-documented. Glucocorticoid might change the glucose metabolism as it induces insulin-resistance. Glucocorticoids are known to reduce the insulin-mediated glucose uptake by reducing the muscle glycogen synthase activity. The effect of a single high dose of glucocorticoid is poorly described in the literature, and therefore calls for further investigation. This study is embedded in a primary study registrated as: NCT02319343 For further details please view the EudraCT registration: EudraCT nr.: 2014-003395-23

Conditions

Interventions

TypeNameDescription
DRUGMethylprednisoloneComparison of preoperative single high dose of Methylprednisolone 125 mg iv. and isotonic Sodium Chloride
DRUGIsotonic Sodium ChloridePlacebo

Timeline

Start date
2015-01-01
Primary completion
2017-01-01
Completion
2017-01-01
First posted
2015-01-07
Last updated
2017-01-18

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02332603. Inclusion in this directory is not an endorsement.